Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- EPAX Expands Purity Standards
Leading Omega-3 Supplier's Purity Standards Now Include Oxidation Parameters, in Addition to Lowering Acceptance Levels of Dioxins, Furans and PCBs
- EPAX Expands Purity Standards
Leading Omega-3 Supplier's Purity Standards Now Include Oxidation Parameters, in Addition to Lowering Acceptance Levels of Dioxins, Furans and PCBs
- First Carbonated Beverage Line Certified 'Glycemic Index Tested'
The Organic Beverage Company, announced the successful completion of human clinical trials establishing the very first carbonated beverage line to be certified as Glycemic Index Tested.
- First Carbonated Beverage Line Certified 'Glycemic Index Tested'
The Organic Beverage Company, announced the successful completion of human clinical trials establishing the very first carbonated beverage line to be certified as Glycemic Index Tested.
- Scientific Research Community Challenged to Consider Broader Spectrum Of Research Beyond RCTs For Studying Nutrition
At a May 3 scientific symposium, The Workshop, presented by the Council for Responsible Nutrition (CRN), the trade association’s President and CEO Steve Mister challenged the audience of scientists to consider whether the drug model for scientific research—relying strictly on randomized clinical trials (RCTs) and evidence-based medicine (EBM)—is the most appropriate research model for nutrients, including dietary supplements.
- Scientific Research Community Challenged to Consider Broader Spectrum Of Research Beyond RCTs For Studying Nutrition
At a May 3 scientific symposium, The Workshop, presented by the Council for Responsible Nutrition (CRN), the trade association’s President and CEO Steve Mister challenged the audience of scientists to consider whether the drug model for scientific research—relying strictly on randomized clinical trials (RCTs) and evidence-based medicine (EBM)—is the most appropriate research model for nutrients, including dietary supplements.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology
John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations.
- Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology
John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations.
- Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology
John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations.
- Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology
John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations.
- Study Finds Biothera Compounds Enhance Human Immune Cell Function
Researchers at Rhode Island Hospital and the Warren Alpert Medical School at Brown University measured the ability of human neutrophils to kill filamentous Candida albicans, determining that Biothera’s yeast-derived beta 1,3/1,6 glucans (Imprime PGG(TM) and WGP(R) 3-6) enhance the anti-microbial function of the neutrophils.
- Study Finds Biothera Compounds Enhance Human Immune Cell Function
Researchers at Rhode Island Hospital and the Warren Alpert Medical School at Brown University measured the ability of human neutrophils to kill filamentous Candida albicans, determining that Biothera’s yeast-derived beta 1,3/1,6 glucans (Imprime PGG(TM) and WGP(R) 3-6) enhance the anti-microbial function of the neutrophils.
- Study Finds Biothera Compounds Enhance Human Immune Cell Function
Researchers at Rhode Island Hospital and the Warren Alpert Medical School at Brown University measured the ability of human neutrophils to kill filamentous Candida albicans, determining that Biothera’s yeast-derived beta 1,3/1,6 glucans (Imprime PGG(TM) and WGP(R) 3-6) enhance the anti-microbial function of the neutrophils.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Enzymotec Presents Successful Trial Findings
Enzymotec' study on the effect of Sharp-PS(TM) PLATINUM on over 60 ADHD schoolchildren, was presented at the 2007 Annual Meeting of the Pediatric Academic Societies (PAS), in Toronto.
- Enzymotec Presents Successful Trial Findings
Enzymotec' study on the effect of Sharp-PS(TM) PLATINUM on over 60 ADHD schoolchildren, was presented at the 2007 Annual Meeting of the Pediatric Academic Societies (PAS), in Toronto.
- Enzymotec Presents Successful Trial Findings
Enzymotec' study on the effect of Sharp-PS(TM) PLATINUM on over 60 ADHD schoolchildren, was presented at the 2007 Annual Meeting of the Pediatric Academic Societies (PAS), in Toronto.
- New Clinical Study In Baby Boomer and Older Health and Fitness Club Members
Improvements in cognitive ability and physical fitness were seen in the
vast majority of participants who participated in eight-week clinical
trial.
- New Clinical Study In Baby Boomer and Older Health and Fitness Club Members
Improvements in cognitive ability and physical fitness were seen in the
vast majority of participants who participated in eight-week clinical
trial.
- New Clinical Study In Baby Boomer and Older Health and Fitness Club Members
Improvements in cognitive ability and physical fitness were seen in the
vast majority of participants who participated in eight-week clinical
trial.
- INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip"
Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.)
- INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip"
Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.)
- INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip"
Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.)
- INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip"
Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.)
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Study shows that grapes may slow the progression of Type I Autoimmune Diabetes in lab mice
A new study appearing in the current issue of the peer-reviewed Journal of Nutrition(1) shows that consuming grapes protected against the destruction of insulin-producing cells (known as beta cells) in the pancreas, significantly reducing the incidence of diabetes in lab rodents.
- Study shows that grapes may slow the progression of Type I Autoimmune Diabetes in lab mice
A new study appearing in the current issue of the peer-reviewed Journal of Nutrition(1) shows that consuming grapes protected against the destruction of insulin-producing cells (known as beta cells) in the pancreas, significantly reducing the incidence of diabetes in lab rodents.
- Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer
In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer.
- Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer
In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer.
- Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer
In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer.
- Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer
In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer.
- Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer
In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer.
- Study: Glucosamine-like supplement inhibits multiple sclerosis, type-1 diabetes
According to University of California, Irvine health sciences researchers, a glucosamine-like dietary supplement (N-acetylglucosamine (GlcNAc)) has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus in mice. The study results appear on the online version of the Journal of Biological Chemistry.
- Study: Glucosamine-like supplement inhibits multiple sclerosis, type-1 diabetes
According to University of California, Irvine health sciences researchers, a glucosamine-like dietary supplement (N-acetylglucosamine (GlcNAc)) has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus in mice. The study results appear on the online version of the Journal of Biological Chemistry.
- New Mouse Study Indicates That Pine Bark Counteracts "Wearing Out" Of the Heart
A mouse study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol(r), natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart.
- New Mouse Study Indicates That Pine Bark Counteracts "Wearing Out" Of the Heart
A mouse study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol(r), natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart.
- New Mouse Study Indicates That Pine Bark Counteracts "Wearing Out" Of the Heart
A mouse study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol(r), natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart.
- Harvard Men’s Health Watch: Red wine protects the prostate
Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption, determining that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine.
- Harvard Men’s Health Watch: Red wine protects the prostate
Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption, determining that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine.
- Harvard Men’s Health Watch: Red wine protects the prostate
Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption, determining that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine.
- Harvard Men’s Health Watch: Red wine protects the prostate
Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption, determining that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine.
- Natural Products Association Challenges New Study on Lung Cancer and Vitamin Use
In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association is questioning the findings being reported at the American Thoracic Society 2007 International Conference, on Monday, May 21, suggesting that taking supplemental multivitamins, vitamin C and E and folate do not decrease the risk of lung cancer.
- Natural Products Association Challenges New Study on Lung Cancer and Vitamin Use
In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association is questioning the findings being reported at the American Thoracic Society 2007 International Conference, on Monday, May 21, suggesting that taking supplemental multivitamins, vitamin C and E and folate do not decrease the risk of lung cancer.
- New Data On the Probiotic Strain Bifantis
Biotechnology company Alimentary Health has announced results from two mice studies presented at the Digestive Disease Week (DDW) conference, which indicate that the natural probiotic bacterial strain of human origin, Bifantis® (Bifidobacterium infantis 35624), was effective in models of arthritis and Salmonella infection.
- New Data On the Probiotic Strain Bifantis
Biotechnology company Alimentary Health has announced results from two mice studies presented at the Digestive Disease Week (DDW) conference, which indicate that the natural probiotic bacterial strain of human origin, Bifantis® (Bifidobacterium infantis 35624), was effective in models of arthritis and Salmonella infection.
- New Data On the Probiotic Strain Bifantis
Biotechnology company Alimentary Health has announced results from two mice studies presented at the Digestive Disease Week (DDW) conference, which indicate that the natural probiotic bacterial strain of human origin, Bifantis® (Bifidobacterium infantis 35624), was effective in models of arthritis and Salmonella infection.
- Meta-analysis: Tonalin® CLA May Help Reduce Fat Mass and Offer Long-Term Health Benefits – Especially for Yo-Yo Dieters
A new meta-analysis of human studies on the efficacy of conjugated linoleic acid (CLA) and body composition, published in the American Journal of Clinical Nutrition1, examined 18 clinical trials (of which 15 used Tonalin® CLA), determining that CLA could enhance overall health by effectively reducing body fat, and potentially preventing weight and fat regain commonly experienced by adults, especially yo-yo dieters.
- Meta-analysis: Tonalin® CLA May Help Reduce Fat Mass and Offer Long-Term Health Benefits – Especially for Yo-Yo Dieters
A new meta-analysis of human studies on the efficacy of conjugated linoleic acid (CLA) and body composition, published in the American Journal of Clinical Nutrition1, examined 18 clinical trials (of which 15 used Tonalin® CLA), determining that CLA could enhance overall health by effectively reducing body fat, and potentially preventing weight and fat regain commonly experienced by adults, especially yo-yo dieters.
- Meta-analysis: Tonalin® CLA May Help Reduce Fat Mass and Offer Long-Term Health Benefits – Especially for Yo-Yo Dieters
A new meta-analysis of human studies on the efficacy of conjugated linoleic acid (CLA) and body composition, published in the American Journal of Clinical Nutrition1, examined 18 clinical trials (of which 15 used Tonalin® CLA), determining that CLA could enhance overall health by effectively reducing body fat, and potentially preventing weight and fat regain commonly experienced by adults, especially yo-yo dieters.
- Mineral Resources International Completes Genotoxicity Safety Studies on ConcenSea(TM) Minerals
Company has announced the results of recently completed, commissioned genotoxicity safety studies of ConcenSea(TM) Mineral Drops, its proprietary, concentrated, low-sodium, liquid mineral complex. The results of the two studies show no genotoxicity in the Ames Assay and the mouse lymphoma assay.
- Mineral Resources International Completes Genotoxicity Safety Studies on ConcenSea(TM) Minerals
Company has announced the results of recently completed, commissioned genotoxicity safety studies of ConcenSea(TM) Mineral Drops, its proprietary, concentrated, low-sodium, liquid mineral complex. The results of the two studies show no genotoxicity in the Ames Assay and the mouse lymphoma assay.
- Study Confirms Chromax(R) Chromium Picolinate is Significantly Better Absorbed Than Other Common Forms of Nutritional Chromium
Company announces that a new human clinical study, conducted by The Ohio State University (OSU) Department of Human Nutrition, published in the June issue of Journal of Trace Elements in Medicine and Biology, shows that Chromax(R) chromium picolinate is significantly better absorbed by the body than other forms of chromium.
- Study Confirms Chromax(R) Chromium Picolinate is Significantly Better Absorbed Than Other Common Forms of Nutritional Chromium
Company announces that a new human clinical study, conducted by The Ohio State University (OSU) Department of Human Nutrition, published in the June issue of Journal of Trace Elements in Medicine and Biology, shows that Chromax(R) chromium picolinate is significantly better absorbed by the body than other forms of chromium.
- Study Examines the Effect of Functional Keratin On Equine Lameness
Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo.
- Study Examines the Effect of Functional Keratin On Equine Lameness
Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo.
- Study Examines the Effect of Functional Keratin On Equine Lameness
Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo.
- Integrative Medicine Consult Service Established at the NIH Clinical Center
The National Center for Complementary and Alternative Medicine (NCCAM) has established an Integrative Medicine Consult Service at the National Institutes of Health (NIH) Clinical Center, the world's largest hospital devoted to research. This service will provide physicians, nurses, and other members of the Clinical Center health care team the ability to discuss complementary and alternative medicine (CAM) therapies with knowledgeable medical staff from the consult service and learn how various CAM practices might complement or interact with a patient's care as a research participant at the Clinical Center.
- Integrative Medicine Consult Service Established at the NIH Clinical Center
The National Center for Complementary and Alternative Medicine (NCCAM) has established an Integrative Medicine Consult Service at the National Institutes of Health (NIH) Clinical Center, the world's largest hospital devoted to research. This service will provide physicians, nurses, and other members of the Clinical Center health care team the ability to discuss complementary and alternative medicine (CAM) therapies with knowledgeable medical staff from the consult service and learn how various CAM practices might complement or interact with a patient's care as a research participant at the Clinical Center.
- Integrative Medicine Consult Service Established at the NIH Clinical Center
The National Center for Complementary and Alternative Medicine (NCCAM) has established an Integrative Medicine Consult Service at the National Institutes of Health (NIH) Clinical Center, the world's largest hospital devoted to research. This service will provide physicians, nurses, and other members of the Clinical Center health care team the ability to discuss complementary and alternative medicine (CAM) therapies with knowledgeable medical staff from the consult service and learn how various CAM practices might complement or interact with a patient's care as a research participant at the Clinical Center.
- Integrative Medicine Consult Service Established at the NIH Clinical Center
The National Center for Complementary and Alternative Medicine (NCCAM) has established an Integrative Medicine Consult Service at the National Institutes of Health (NIH) Clinical Center, the world's largest hospital devoted to research. This service will provide physicians, nurses, and other members of the Clinical Center health care team the ability to discuss complementary and alternative medicine (CAM) therapies with knowledgeable medical staff from the consult service and learn how various CAM practices might complement or interact with a patient's care as a research participant at the Clinical Center.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease, according to two reports in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Age-related macular degeneration (AMD) occurs when the macula, the area at the back of the retina that produces the sharpest vision, deteriorates over time. It is the most common cause of blindness among older adults in the United States, affecting more than 7 million individuals older than 40 years, according to background information in the articles. The prevalence of AMD is likely to increase as the population ages. There is currently no known way to prevent the condition, but research has begun to identify potentially modifiable risk factors and nutrient-based treatments.
The Age-Related Eye Disease Study Research Group assessed 4,519 individuals who were age 60 to 80 when they enrolled in 1992 through 1998. At that time, photographs were taken of their retinas to determine if they had AMD, and if so, to which of four stages the condition had progressed. The participants also completed a food frequency questionnaire that measured how often they consumed foods rich in certain vitamins, minerals and other nutrients, such as omega-3 fatty acids commonly found in tuna, salmon and other fish.
A total of 1,115 participants did not have any symptoms of AMD at the beginning of the study, and were compared with those who did, including 658 individuals with neovascular (severe) AMD. "Dietary total omega-3 long-chain polyunsaturated fatty acid intake was inversely associated with neovascular AMD, as was docosahexaenoic acid," or DHA, a fatty acid that previous evidence suggests affects the retina, the authors write. "Higher fish consumption, both total and broiled/baked, was also inversely associated with neovascular AMD." Eating more than two medium (4-ounce) servings of fish per week or more than one medium serving of broiled or baked fish was associated with the lowest risk for advanced AMD.
Omega-3 fatty acids may influence processes involved in the development of blood vessel– and nerve-related diseases of the retina, the authors write. For instance, DHA may protect the retina by influencing which genes turn on and off, while fatty acids overall may eventually form compounds that promote cell survival and proper blood vessel function, reduce inflammation and maintain energy balance.
"These results and those from other observational analytic investigations suggest that modifying diet to include more foods rich in omega-3 long-chain polyunsaturated fatty acids could result in a reduction in the risk of having neovascular AMD," the authors conclude. Clinical trials would provide further information about whether diet changes or supplements could prevent the development of advanced AMD.
In a related study, Niyati Parekh, Ph.D., R.D., of the University of the Medicine and Dentistry of New Jersey, New Brunswick, and the University of Wisconsin–Madison, and colleagues analyzed data from 7,752 individuals (including 11 percent with AMD) who were part of the National Health and Nutrition Examination Survey, a large study designed to represent the entire U.S. population. Participants were enrolled in the study between 1988 and 1994. They had physical examinations that included blood and urine samples, photographs of the retinas, and interviews and questionnaires regarding sociodemographics, lifestyle habits and food intake.
"Levels of serum vitamin D were inversely associated with early AMD but not advanced AMD," the authors write. When participants were split into five groups based on level of vitamin D in the blood, those in the highest group had a 40 percent lower risk of early AMD than those in the lowest group. "Milk intake was inversely associated with early AMD. Fish intake was inversely associated with advanced AMD."
Vitamin D may reduce the risk of AMD by reducing inflammation or by preventing the growth of new blood vessels in the retina, which contributes to some forms of AMD, the authors speculate. "This study provides evidence that vitamin D may protect against AMD," the authors conclude. "However, at this time there is insufficient epidemiologic evidence of the relationship between vitamin D level and AMD to make recommendations regarding optimum serum vitamin D levels or milk and fish intake to protect against AMD or its progression. The results of the present research warrant further investigation for confirmation of the vitamin D-AMD association in other population studies."
###
(Arch Ophthalmol. 2007;125:661-669, 671-679.) |